Description
Among the growing list of therapeutic peptides, 5-Amino-1MQ stands out as a uniquely oral option that supports visceral fat loss, insulin sensitivity, and NAD+ production—without the need for injections. But unlike some peptides that can be taken continuously, 5-Amino-1MQ works best when cycled. Its effects tend to diminish after 4–6 weeks of daily use, so strategic breaks are essential to reset the body’s responsiveness and restore its full effectiveness.
5-Amino-1MQ, short for 5-Amino-1-methylquinolinium, is a small molecule peptide analog that inhibits the enzyme nicotinamide N-methyltransferase (NNMT). This enzyme is overactive in individuals with excess abdominal fat and metabolic dysfunction. By inhibiting NNMT, 5-Amino-1MQ boosts intracellular NAD+, enhances mitochondrial function, and helps promote the breakdown of visceral fat.
